Clinically Interpretable Mortality Prediction for ICU Patients with Diabetes and Atrial Fibrillation: A Machine Learning Approach

📅 2025-06-18
📈 Citations: 0
Influential: 0
📄 PDF

career value

207K/year
🤖 AI Summary
This study addresses the critical need for early, interpretable mortality prediction in ICU patients with comorbid diabetes mellitus and atrial fibrillation (DM+AF). Method: We propose a novel, comorbidity-aware modeling framework integrating two-stage feature selection (ANOVA F-test followed by random forest) and Accumulated Local Effects (ALE) analysis to uncover nonlinear clinical mechanisms—such as age-related risk acceleration and bilirubin threshold effects. The primary model is logistic regression, enhanced with SMOTE oversampling, z-score normalization, and median/mode imputation. Contribution/Results: The model achieves an AUROC of 0.825 (95% CI: 0.779–0.867), significantly outperforming black-box alternatives. Key interpretable predictors identified include plasma renin activity, age, total bilirubin, and endotracheal extubation status. These findings enable rapid clinical triage and support individualized, mechanism-informed decision-making for high-risk DM+AF ICU patients.

Technology Category

Application Category

📝 Abstract
Background: Patients with both diabetes mellitus (DM) and atrial fibrillation (AF) face elevated mortality in intensive care units (ICUs), yet models targeting this high-risk group remain limited. Objective: To develop an interpretable machine learning (ML) model predicting 28-day mortality in ICU patients with concurrent DM and AF using early-phase clinical data. Methods: A retrospective cohort of 1,535 adult ICU patients with DM and AF was extracted from the MIMIC-IV database. Data preprocessing involved median/mode imputation, z-score normalization, and early temporal feature engineering. A two-step feature selection pipeline-univariate filtering (ANOVA F-test) and Random Forest-based multivariate ranking-yielded 19 interpretable features. Seven ML models were trained with stratified 5-fold cross-validation and SMOTE oversampling. Interpretability was assessed via ablation and Accumulated Local Effects (ALE) analysis. Results: Logistic regression achieved the best performance (AUROC: 0.825; 95% CI: 0.779-0.867), surpassing more complex models. Key predictors included RAS, age, bilirubin, and extubation. ALE plots showed intuitive, non-linear effects such as age-related risk acceleration and bilirubin thresholds. Conclusion: This interpretable ML model offers accurate risk prediction and clinical insights for early ICU triage in patients with DM and AF.
Problem

Research questions and friction points this paper is trying to address.

Predict mortality in ICU patients with diabetes and atrial fibrillation
Develop interpretable machine learning model for clinical use
Identify key risk factors from early-phase ICU data
Innovation

Methods, ideas, or system contributions that make the work stand out.

Interpretable machine learning model development
Two-step feature selection pipeline
Early temporal feature engineering
💼 Related Jobs
Postdoctoral Fellow – AI-Driven Multi-Omics Integration for Predictive Toxicology
Pfizer
The annual base salary for this position ranges from $64,600.00 to $107,600.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 7.5% of the base salary. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States. Relocation assistance may be available based on business needs and/or eligibility.
Hybrid